APOE and Alzheimer disease: In addition, cerebral edema and microhemorrhages (referred to as amyloid related imaging abnormalities; ARIA) remain a prominent concern of these mAbs, especially for APOE4 carriers, who are at the greatest genetic risk for late-onset AD.